Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Christgen

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Disease Markers|June 12, 2012
Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancerMaximilian Knoener, Till Krech, Florian Puls, et al.
Molecular and Cellular Biochemistry|July 31, 2007
Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell lineMatthias Christgen, Matthias Ballmaier, Henriette Bruchhardt, et al.
Cancer Biology & Therapy|January 22, 2005
Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell lineBodo Schniewind, Matthias Christgen, Axel Hauschild, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Concerted deregulations of multiple apoptosis-controlling genes in pancreatic carcinoma cellsAnna Trauzold, Stefan Schmiedel, Stephanie Oestern, et al.
Cancer Science|June 25, 2009
Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancerMatthias Christgen, Henriette Christgen, Charlotte Heil, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 12, 2017
Estrogen receptor (ESR1) mutation in bone metastases from breast cancerStephan Bartels, Matthias Christgen, Angelina Luft, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2018
Activating human epidermal growth factor receptor 2 (HER2) gene mutation in bone metastases from breast cancerMatthias Christgen, Stephan Bartels, Angelina Luft, et al.
International Journal of Cancer|August 21, 2008
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancerMatthias Christgen, Henriette Bruchhardt, Matthias Ballmaier, et al.
Pathology, Research and Practice|May 29, 2016
Lobular breast cancer: Clinical, molecular and morphological characteristicsMatthias Christgen, Doris Steinemann, Elna Kühnle, et al.
International Journal of Cancer|January 30, 2004
Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosisBodo Schniewind, Matthias Christgen, Roland Kurdow, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Disease Markers|June 12, 2012
Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancerMaximilian Knoener, Till Krech, Florian Puls, et al.
Molecular and Cellular Biochemistry|July 31, 2007
Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell lineMatthias Christgen, Matthias Ballmaier, Henriette Bruchhardt, et al.
Cancer Biology & Therapy|January 22, 2005
Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell lineBodo Schniewind, Matthias Christgen, Axel Hauschild, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Concerted deregulations of multiple apoptosis-controlling genes in pancreatic carcinoma cellsAnna Trauzold, Stefan Schmiedel, Stephanie Oestern, et al.
Cancer Science|June 25, 2009
Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancerMatthias Christgen, Henriette Christgen, Charlotte Heil, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 12, 2017
Estrogen receptor (ESR1) mutation in bone metastases from breast cancerStephan Bartels, Matthias Christgen, Angelina Luft, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2018
Activating human epidermal growth factor receptor 2 (HER2) gene mutation in bone metastases from breast cancerMatthias Christgen, Stephan Bartels, Angelina Luft, et al.
International Journal of Cancer|August 21, 2008
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancerMatthias Christgen, Henriette Bruchhardt, Matthias Ballmaier, et al.
Pathology, Research and Practice|May 29, 2016
Lobular breast cancer: Clinical, molecular and morphological characteristicsMatthias Christgen, Doris Steinemann, Elna Kühnle, et al.
International Journal of Cancer|January 30, 2004
Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosisBodo Schniewind, Matthias Christgen, Roland Kurdow, et al.
Pageof 11